Nakul Shah (@nakul2234) 's Twitter Profile
Nakul Shah

@nakul2234

Oncology Fellow MDACC | Former WashU Internal Medicine | Former HHMI Medical Fellow | Genomics 🧬 Researcher Searching 🔎 for Therapeutic Targets 🎯

ID: 2290045190

calendar_today13-01-2014 18:20:54

48 Tweet

170 Followers

159 Following

NCI CTEP Clinical Research (@ncictep_clinres) 's Twitter Profile Photo

Important finding #ASCO24: “Association between circulating tumor DNA and recurrence-free survival in patients with resected stage III melanoma: An exploratory analysis of SWOG Cancer Research Network S1404”! Join the poster discussion on June 1st, 1:30 PM – 4:30 PM CDT. More: buff.ly/4dXGXR1

Important finding #ASCO24: “Association between circulating tumor DNA and recurrence-free survival in patients with resected stage III melanoma: An exploratory analysis of <a href="/SWOG/">SWOG Cancer Research Network</a> S1404”! Join the poster discussion on June 1st, 1:30 PM – 4:30 PM CDT. More: buff.ly/4dXGXR1
Michael LaPelusa, MD (@michaellapelusa) 's Twitter Profile Photo

Be sure to check out Dr. Kaysia Ludford present 3-year follow up data in patients with locally advanced dMMR/MSI-H solid tumors treated with pembrolizumab! MD Anderson Cancer Center ESMO - Eur. Oncology #ESMO24

Ju-Heon Maeng (@juheonm) 's Twitter Profile Photo

My last PhD project on epigenetic-treatment-induced novel antigens in glioblastoma is out. It was a privilege to work with the co-first authors, joshhjang, Nakul Shah, and Yonghao Liang, and mentors, Albert H. Kim and Ting Wang. Please read for more: nature.com/articles/s4158….

My last PhD project on epigenetic-treatment-induced novel antigens in glioblastoma is out. It was a privilege to work with the co-first authors, <a href="/joshhjang/">joshhjang</a>, <a href="/Nakul2234/">Nakul Shah</a>, and <a href="/leung_holden/">Yonghao Liang</a>, and mentors, <a href="/AlbertHKimMDPhD/">Albert H. Kim</a> and <a href="/twang5/">Ting Wang</a>. Please read for more:  nature.com/articles/s4158….
Eric K. Singhi, MD (@lungoncdoc) 's Twitter Profile Photo

Our Dr. Xiuning Le MD PhD presents a key update for patients with HER2 positive NSCLC from the phase 1/2 SOHO-01 study. BAY 2927088 -Oral reversible TKI -ORR 72% (90% in YMVA) -mDOR 8.7 mos -mPFS 7.5 mos -AE: 25% grade 3+ diarrhea #WCLC24 #LCSM OncoAlert

Our Dr. <a href="/LeXiuning/">Xiuning Le MD PhD</a> presents a key update for patients with HER2 positive NSCLC from the phase 1/2 SOHO-01 study.

BAY 2927088
-Oral reversible TKI
-ORR 72% (90% in YMVA)
-mDOR 8.7 mos
-mPFS 7.5 mos
-AE: 25% grade 3+ diarrhea

#WCLC24 #LCSM <a href="/OncoAlert/">OncoAlert</a>
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Terrific list of ADC data to be presented at #ESMO24 Most abstracts already available Some showing impressive response rates in hard-to-treat cancers 👇

Cecilia Pessoa (@cica_dups) 's Twitter Profile Photo

Thrilled to share my paper! 🙌science.org/doi/10.1126/sc… It was an incredible experience working and exploring such a fascinating story. Huge thanks all co-authors, they r amazing ppl, and everyone in the Zon Lab Dr. Len Zon for all their support both in and out of the lab! 😍

Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Pembrolizumab + CAPOX /bevacizumab in MSS CRC and a high immune infiltrate #ESMO24 🔎POCHI trial 👉ORR 74%, DRC 100%, 5 CR 👉12-mo PFS rate 51% 👉2-yr OS rate 80% 👉AEs ≥3 70% 🧐IMMUNOSCORE and TuLIS score (18% of pts) to select ICI in mCRC? ESMO - Eur. Oncology #ESMOAmbassadors

Pembrolizumab + CAPOX /bevacizumab in MSS CRC and a high immune infiltrate #ESMO24 
🔎POCHI trial
👉ORR 74%, DRC 100%, 5 CR
👉12-mo PFS rate 51%
👉2-yr OS rate 80%
👉AEs ≥3 70% 
🧐IMMUNOSCORE and TuLIS score (18% of pts) to select ICI in mCRC?
<a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOAmbassadors
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

New study in Nature Medicine from Scott Kopetz MD Anderson Cancer Center and colleagues Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial nature.com/articles/s4159… The putative genomic mechanisms of resistance (on ctDNA) illustrated below

New study in <a href="/NatureMedicine/">Nature Medicine</a> from <a href="/skopetz/">Scott Kopetz</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> and colleagues 
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
nature.com/articles/s4159…
The putative genomic mechanisms of resistance (on ctDNA) illustrated below
Sangeeta Goswami, MD,PhD (@sgoswamimdphd) 's Twitter Profile Photo

I am happy to share the latest paper from Goswami_Lab in Nature Immunology. We showed the integration of metabolic & epigenetic pathways regulating CD8 T cell mediated anti tumor immunity via histone lactylation. ⁦Deblina Raychaudhuri⁩⁦@RaiPratishtha⁩⁦MD Anderson Cancer Center

I am happy to share the latest paper from Goswami_Lab in Nature Immunology. We showed the integration of metabolic &amp; epigenetic pathways regulating CD8 T cell mediated anti tumor immunity via histone lactylation. ⁦<a href="/DeblinaRC/">Deblina Raychaudhuri</a>⁩⁦@RaiPratishtha⁩⁦<a href="/MDAndersonNews/">MD Anderson Cancer Center</a>⁩
Nazli Dizman (@nazlidizman) 's Twitter Profile Photo

🎉Immensely excited and proud to share with you our recent paper "Guide to Understanding and Supporting #InternationalMedicalGraduates in #Hematology #Oncology" with gratitude to my co-first author Ziad Bakouny, MD, MSc, senior authors Toni Choueiri, MD #DrAlfredLee, and other world-renowned

🎉Immensely excited and proud to share with you our recent paper "Guide to Understanding and Supporting #InternationalMedicalGraduates in #Hematology #Oncology" with gratitude to my co-first author <a href="/ZiadBakouny/">Ziad Bakouny, MD, MSc</a>, senior authors <a href="/DrChoueiri/">Toni Choueiri, MD</a> #DrAlfredLee, and other world-renowned